Simris Alg AB (publ) (SIMRIS-B.ST) Research
Operating both within Sweden and across global markets, Simris Alg AB (publ) specializes in the production and sale of nutritional supplements and food products derived from algae. Its product portfolio includes Simris Algae Omega-3, a unique plant-derived marine omega-3 supplement providing both EPA and DHA. Additionally, under its 'Simris Select' brand, the company provides a range of other algae-based items like premium chlorella, spirulina sprinkles, invigorating astaxanthin, and various algae teas such as 'flower power' and 'sun candy'. Established in 2010, the firm maintains its main office in Hammenhög, Sweden.
Market snapshot
- Symbol
- SIMRIS-B.ST
- Price
- $0.09
- Day change
- +2.39%
- Market cap
- $50.8M
- P/E ratio
- -2.64x
- 52-week range
- 0.0402-0.249
- Sector
- Healthcare
- Industry
- Biotechnology
Peer companies
- AcouSort AB (publ) (ACOU.ST)
- Alligator Bioscience AB (publ) (ATORX.ST)
- ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)
- Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
- Modus Therapeutics Holding AB (publ) (MODTX.ST)
- Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
- OncoZenge AB (publ) (ONCOZ.ST)
- Ortivus AB (publ) (ORTI-B.ST)
Open Simris Alg AB (publ) (SIMRIS-B.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.